The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
Condition(s):Non-small Cell Lung Cancer; Extensive Disease Small Cell Lung CancerLast Updated:March 26, 2021Unknown status